Breaking News Instant updates and real-time market news.

TSLA

Tesla

$510.34 /

-3.065 (-0.60%)

16:04
01/20/20
01/20
16:04
01/20/20
16:04

Tesla rebuffs U.S. safety recall petition, Reuters reports

Tesla said there was no unintended acceleration in its vehicles, as it responded to a petition to a U.S. safety regulator to investigate and recall around 500,000 of the company's electric cars over the alleged defect, according to Reuters. On Friday, the National Highway Traffic Safety Administration said it would review the petition and released a redacted version that said "Tesla vehicles experience unintended acceleration at rates far exceeding other cars on the roads." Reference Link

  • 29

    Jan

  • 24

    Feb

  • 23

    Mar

  • 23

    Mar

TSLA Tesla
$510.34 /

-3.065 (-0.60%)

01/16/20
Fly Intel: Top five analyst downgrades
01/16/20 Morgan Stanley
Morgan Stanley downgrades Tesla to Underweight on valuation after 105% rally
01/16/20 Morgan Stanley
Tesla downgraded to Underweight from Equal Weight at Morgan Stanley
01/14/20 Deutsche Bank
Deutsche raises Tesla target to $455 from $290 despite sentiment concerns

TODAY'S FREE FLY STORIES

Hot Stocks
Realogy renames operating segments » 07:23
02/25/20
02/25
07:23
02/25/20
07:23
RLGY

Realogy

$12.88 /

-0.23 (-1.75%)

, BID

Sotheby's

$0.00 /

+ (+0.00%)

Realogy announced a new…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
HP Inc. upgraded to Buy from Hold at Loop Capital » 07:23
02/25/20
02/25
07:23
02/25/20
07:23
HPQ

HP Inc.

$22.13 /

-0.55 (-2.43%)

, XRX

Xerox

$34.90 /

-1.45 (-3.99%)

Loop Capital analyst…

Loop Capital analyst Ananda Baruah upgraded HP Inc. (HPQ) to Buy from Hold with a price target of $28, up from $19. The stock closed Monday down 60c to $22.10. The company's earnings call included a handful of announcements that suggest the stock "continues to move higher from here through various means," Baruah tells investors in a research note. These include HP's new buyback as well as an incremental cost saves plan that places 2022 earnings per share at $3.25, says the analyst. Further, Baruah notes that HP stated it would be contacting Xerox (XRX) to see if a deal could be reached that appropriately rewards its shareholders.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Evolus reports Q4 EPS (47c), consensus (73c) » 07:22
02/25/20
02/25
07:22
02/25/20
07:22
EOLS

Evolus

$9.35 /

-0.89 (-8.69%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Home Depot outlook affirmed with upside bias seen, says Baird » 07:21
02/25/20
02/25
07:21
02/25/20
07:21
HD

Home Depot

$239.77 /

-5.56 (-2.27%)

Baird analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Palo Alto Networks price target lowered to $240 from $275 at Wedbush » 07:21
02/25/20
02/25
07:21
02/25/20
07:21
PANW

Palo Alto Networks

$236.99 /

-5.87 (-2.42%)

Wedbush analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Intuit price target raised to $320 from $303 at BofA » 07:20
02/25/20
02/25
07:20
02/25/20
07:20
INTU

Intuit

$286.50 /

-11.27 (-3.78%)

BofA analyst Kash Rangan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Montage Resources reports Q4 net production averaged 623.4 MMcfe per day » 07:19
02/25/20
02/25
07:19
02/25/20
07:19
MR

Montage Resources

$3.39 /

-0.255 (-7.00%)

Net production for the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Chimerix expects to submit BCV NDA for smallpox in mid-2020 » 07:19
02/25/20
02/25
07:19
02/25/20
07:19
CMRX

Chimerix

$1.75 /

+0.025 (+1.45%)

In January, Chimerix…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Dine Brands price target raised to $110 from $100 at Wedbush » 07:18
02/25/20
02/25
07:18
02/25/20
07:18
DIN

Dine Brands

$96.06 /

-1.13 (-1.16%)

Wedbush analyst Nick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Chimerix to initiate Phase 3 trial of DSTAT w/ chemotherapy mid-year » 07:18
02/25/20
02/25
07:18
02/25/20
07:18
CMRX

Chimerix

$1.75 /

+0.025 (+1.45%)

Chimerix recently…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
United Airlines' long-term opportunity remains, says BofA » 07:17
02/25/20
02/25
07:17
02/25/20
07:17
UAL

United Airlines

$75.46 /

-2.56 (-3.28%)

BofA analyst Andrew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Duke Realty management to meet with SunTrust » 07:17
02/25/20
02/25
07:17
02/25/20
07:17
DRE

Duke Realty

$37.71 /

-1.12 (-2.88%)

Dinner Meeting to be held…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Lantheus sees FY20 adj. EPS $1.34-$1.40, consensus $1.03 » 07:16
02/25/20
02/25
07:16
02/25/20
07:16
LNTH

Lantheus

$16.11 /

-0.46 (-2.78%)

Sees FY20 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Chimerix reports Q4 EPS (6c), two est. (17c) » 07:16
02/25/20
02/25
07:16
02/25/20
07:16
CMRX

Chimerix

$1.75 /

+0.025 (+1.45%)

Reports Q4 revenue $6.8M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Aeglea BioTherapeutics price target raised to $24 from $20 at H.C. Wainwright » 07:16
02/25/20
02/25
07:16
02/25/20
07:16
AGLE

Aeglea BioTherapeutics

$7.42 /

-0.42 (-5.36%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
United Therapeutics price target raised to $243 from $237 at Wedbush » 07:15
02/25/20
02/25
07:15
02/25/20
07:15
UTHR

United Therapeutics

$115.29 /

+8.33 (+7.79%)

Wedbush analyst Liana…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Nutrien announces TSX approval for renewed share repurchase program » 07:15
02/25/20
02/25
07:15
02/25/20
07:15
NTR

Nutrien

$42.02 /

-0.555 (-1.30%)

Nutrien announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Epizyme price target raised to $36 from $25 at H.C. Wainwright » 07:14
02/25/20
02/25
07:14
02/25/20
07:14
EPZM

Epizyme

$21.65 /

-3.24 (-13.02%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Lantheus sees Q1 adj. EPS 25c-27c, one estimate 3c » 07:14
02/25/20
02/25
07:14
02/25/20
07:14
LNTH

Lantheus

$16.11 /

-0.46 (-2.78%)

Sees Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Proteostasis announces publication of of nonclinical data on PTI-428 » 07:14
02/25/20
02/25
07:14
02/25/20
07:14
PTI

Proteostasis

$1.94 /

-0.05 (-2.51%)

Proteostasis Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
MediWound sees 2020 cash use $11M-$13M » 07:13
02/25/20
02/25
07:13
02/25/20
07:13
MDWD

MediWound

$2.93 /

-0.04 (-1.35%)

As of December 31, 2019,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
JPMorgan sees medium-term ROTCE target 17% » 07:13
02/25/20
02/25
07:13
02/25/20
07:13
JPM

JPMorgan

$132.16 /

-3.65 (-2.69%)

Sees medium-term overhead…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
JPMorgan sees NII falling to $57B in 2020 » 07:13
02/25/20
02/25
07:13
02/25/20
07:13
JPM

JPMorgan

$132.16 /

-3.65 (-2.69%)

Sees NII of $60B+/- in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Royal Caribbean removed from Best Ideas List at Wedbush » 07:12
02/25/20
02/25
07:12
02/25/20
07:12
RCL

Royal Caribbean

$96.53 /

-9.56 (-9.01%)

Wedbush is removing Royal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Lantheus reports Q4 adj. EPS 34c, consensus 30c » 07:12
02/25/20
02/25
07:12
02/25/20
07:12
LNTH

Lantheus

$16.11 /

-0.46 (-2.78%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.